Submissions from 2024
Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce, Manmeet Ahluwalia
Comparison of Stereotactic Radiosurgery and Hypofractionated Radiosurgery for Vestibular Schwannomas: A Meta-Analysis of Available Literature, Manmeet Ahluwalia
HER2+ early breast cancer treatment and outcomes by risk of recurrence: a retrospective US electronic health records study, Reshma Mahtani
Multicenter retrospective cohort study of the sequential use of antibody drug conjugates (ADCs) trastuzumab deruxtecan (T-DXd) and sacituzumab govitecan (SG) in patients with HER2 low metastatic breast cancer (MBC): a subgroup analysis of next generation sequencing results., Reshma Mahtani, Mehmet Zerey, Ana Cristina Sandoval Leon, Lauren Carcas, Joseph Panoff, and Manmeet Ahluwalia
Multi-Institutional Quality Improvement on HER2-Positive and HER2-Low Metastatic Breast Cancer, Reshma Mahtani
Sequencing Sacituzumab Govitecan (SG) AfteR Trastuzumab Deruxtecan (T-DXd) In ER+/HER2 LOW MetaStatic Breast Cancer, Reshma Mahtani, Ana Cristina Sandoval Leon, Maria Abreu, and Manmeet Ahluwalia
Evaluation of a Partial Single Arc For Prostate SBRT Proton Treatment Planning According To RTOG 0938 Protocol, Suresh Rana
Dosimetric comparison of magnetic resonance-guided radiation therapy, intensity-modulated proton therapy and volumetric-modulated arc therapy for distal esophageal cancer, Andrew Barsky, Andrew Wroe, Kathryn Mittauer, Adeel Kaiser, Roberto Herrera, Jen Yu, Alonso Gutierrez, Diane Alvarez, James McCulloch, Michael Kasper, Minesh Mehta, and Michael Chuong
Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group, Noah Kalman and Robert Press
SBRT vs. Conventional Radiotherapy for Painful Spinal Metastases: A Comparative Analysis of Randomized Trials and Practical Considerations, Omer Gal, Robert Rothrock, Alonso Gutierrez, Minesh Mehta, and Rupesh Kotecha
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
The IDH paradox: Meta-analysis of alkylating chemotherapy in IDH-wildtype and -mutant lower grade gliomas, Minesh Mehta
NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma, Minesh Mehta
Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases, Manmeet Ahluwalia
Phase I trial of dose escalation for preoperative stereotactic radiosurgery for patients with large brain metastases, Manmeet Ahluwalia
An Update on H3K27M-altered Diffuse Midline Glioma: Diagnostic and Therapeutic Challenges in Clinical Practice, Eyub Akdemir, Yazmin Odia, Matthew Hall, Minesh Mehta, and Rupesh Kotecha
Clinical application of an institutional fractionated stereotactic radiosurgery (FSRS) program for brain metastases delivered with MRIdian(Ⓡ) BrainTx™, Alonso La Rosa De Los Rios, Kathryn Mittauer, D Jay Wieczorek, Cecilia Lee, Amy Rzepczynski, Michael Chuong, Tugce Kutuk, Nicole McAllister, Matthew Hall, Alonso Gutierrez, Ranjini Tolakanahalli, Minesh Mehta, and Rupesh Kotecha
Modified Bethesda criteria for thyroid aspirates significantly decrease nondiagnostic rates without decreasing sensitivity, Andrew Renshaw, Brian Schiro, Neeta Erinjeri, and Robert Udelsman
Tumor-Intrinsic Galectin-3 Suppresses Melanoma Metastasis, Manmeet Ahluwalia
Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access, Horacio Asbun and Domenech Asbun
Evaluating the Base Excision Repair Inhibitor TRC102 and Temozolomide for patients with Recurrent Glioblastoma in the Phase 2 Adult Brain Tumor Consortium Trial BERT, Manmeet Ahluwalia and Ahmad Ozair
The joy of surgery: how gender influences surgeons' experiences, Horacio Asbun